|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Pulmonary Disease Veterans Affairs Medical Center, and Department of Medicine, University of Minnesota School of Medicine, Minneapolis
2 From the General Internal Medicine Divisions Veterans Affairs Medical Center, and Department of Medicine, University of Minnesota School of Medicine, Minneapolis
Study objective: To determine the diagnostic and prognostic significance of eosinophilic pleural effusions.
Design: A prospective cohort study of patients undergoing thoracentesis between September 1990 and September 1995.
Setting: A university-affiliated VA Medical Center.
Patients: Four hundred seventy-six consecutive patients.
Measurements and results: Eosinophilic pleural effusions were identified in 44 of the 476 patients (9.2%). Malignancy was diagnosed as frequently in eosinophilic as in noneosinophilic effusions (20.5% vs 20.1%). The only diagnoses that were significantly associated with eosinophilic effusions were idiopathic (25% vs 8%; p=0.001) and postthoracic surgery (11% vs 3%; p=0.023). Median survival was 7.7 months for those with a noneosinophilic effusion compared to 16.8 months for those with eosinophilia (p=0.017). This difference in survival persisted after adjustment for age and diagnois.
Conclusions: We conclude that malignancy is as prevalent among eosinophilic as noneosinophilic pleural effusions. However, the survival of patients with pleural fluid eosinophilia may be better than that of patients with noneosinophilic effusions.
Key Words: eosinophilia pleural effusion thoracentesis
Submitted on February 7, 1996
Accepted on April 18, 2007
This article has been cited by other articles:
![]() |
S. N. Georas, L. A. Beck, and C. Stellato What Is Eotaxin Doing in the Pleura? . Insights into Innate Immunity from Pleural Mesothelial Cells Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 384 - 387. [Full Text] [PDF] |
||||
![]() |
H. Katayama, A. Yokoyama, N. Kohno, K. Sakai, K. Hiwada, H. Yamada, and K. Hirai Production of Eosinophilic Chemokines by Normal Pleural Mesothelial Cells Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 398 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Romero Candeira, L. Hernandez Blasco, M. J. Soler, A. Munoz, and I. Aranda Biochemical and Cytologic Characteristics of Pleural Effusions Secondary to Pulmonary Embolism Chest, February 1, 2002; 121(2): 465 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn Management of malignant pleural effusions Eur. Respir. J., August 1, 2001; 18(2): 402 - 419. [Full Text] [PDF] |
||||
![]() |
Management of Malignant Pleural Effusions Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |